TWST
Twist Bioscience CorpNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.45B
P/E Ratio
—
EPS
$-1.18
Beta
2.23
52W High
$66.06
52W Low
$23.30
50-Day MA
$50.82
200-Day MA
$37.56
Dividend Yield
—
Profit Margin
-19.60%
Forward P/E
—
PEG Ratio
—
About Twist Bioscience Corp
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $391.56M |
| Gross Profit (TTM) | $202.13M |
| EBITDA | $-112.75M |
| Operating Margin | -31.70% |
| Return on Equity | -16.80% |
| Return on Assets | -13.50% |
| Revenue/Share (TTM) | $6.50 |
| Book Value | $7.44 |
| Price-to-Book | 8.12 |
| Price-to-Sales (TTM) | 8.80 |
| EV/Revenue | 9.2 |
| EV/EBITDA | -35.26 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 16.90% |
| Shares Outstanding | $61.31M |
| Float | $54.65M |
| % Insiders | 1.43% |
| % Institutions | 121.19% |
Historical Volatility
HV 10-Day
66.00%
HV 20-Day
76.94%
HV 30-Day
75.79%
HV 60-Day
71.81%
HV Rank
82.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($55.00 target)
1
Strong Buy7
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026